Creating a world where access to biomedical data will never again be an obstacle for curing diseases
In short
Lifebit, founded in 2017 and led by CEO Dr Maria Chatzou Dunford, builds the Federated Trusted Research Environment used by national genomics programs, health systems and pharma, with offices in London and New York.
Our mission
Lifebit is a precision medicine software company that builds enterprise data platforms for use by organizations with sensitive genomic and biomedical datasets, empowering therapeutic leaders to access and analyze siloed biomedical data.
Generating large amounts of biomedical data has become relatively straightforward. The challenge now is how organizations can access and utilize data stored across thousands of disconnected locations. It is painfully difficult or impossible today.
Lifebit has created a patented technology that enables researchers to run analyses on multiple, distributed datasets in-situ and avoid risky movement of highly-sensitive data.
Dr. Maria Chatzou Dunford
"All biomedical data that can be used to save lives should be used."
Our Investors
Memberships
Certificates & Associations
FAQ
About Lifebit: common questions
When was Lifebit founded?
Lifebit (Lifebit Biotech) was founded in 2017.
Who leads Lifebit?
Dr Maria Chatzou Dunford is Lifebit's CEO.
Where are Lifebit's offices?
London (207 Regent Street) and New York (228 East 45th Street).
What has Lifebit patented?
US Patent 12,519,781, for federated computational discovery across heterogeneous biomedical data.
Join our team
At Lifebit, we carve our own path. Join our team of bioinformaticians, clinical researchers, engineers, innovators and creative business-driven experts.
